Menopausal Hot Flashes Treatment Market is expected to grow at a CAGR of 6% during 2019 - 2027

Menopausal Hot Flashes Treatment Market: Overview

• Menopause is defined as the permanent cessation of menses that may occur in as early as the thirties or as late as the sixties. The treatment and management of menopausal women has been a matter of great apprehension in the last few decades, both in terms of epidemiology and medical scientific research.
• The most common menopausal symptoms, including vasomotor symptoms (menopausal hot flashes), insomnia, vaginal atrophy, altered cognitive function, dementia, depression, and loss of muscle mass, can affect up to 80% of women during menopause and may be severe in up to 20% of these women

Request a Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2856

• Menopausal hot flashes symptoms treatment drugs are used to reduce hot flashes, which is a form of temperature dysfunction that occurs due to changes in gonadal hormones. Menopausal hot flashes symptom treatments are classified into hormonal treatment, non-hormonal treatment, and alternative treatment (including herbal products).
• Hormonal treatment products are available in different dosage forms such as pill, patch, and gel. The use of hormone replacement therapy (HRT) alleviates menopausal hot flashes symptoms and leads to a major improvement in quality of life for women with menopausal hot flashes symptoms.
• Growing population of elderly women worldwide coupled with rise in menopausal hot flashes symptoms is a major factor responsible for the growth of global menopausal hot flashes treatment market
• Increase in awareness about women’s health due to different public as well as private organizations initiatives is also fueling the growth of global menopausal hot flashes treatment market
• Moreover, development of advanced products with alternative mode of administration and changes in lifestyle associated with early menopause are some of the major factors attributed for the growth of global menopausal hot flashes treatment market

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=2856

Market Segmentation: Menopausal Hot Flashes Treatment Market

• Based on treatment type, the global menopausal hot flashes treatment market has been divided into hormonal treatment, non-hormonal treatment, and alternative treatment
• Hormonal treatment is further classified into estrogen, progesterone, and estrogen - progesterone combination
• The non-hormonal segment is sub-segmented into antidepressant, gabapentin, pregabalin, and clonidine. Antidepressant is further divided into Paroxetine, Fluoxetine, Vanlafaxine, Desvanlafaxine, and others.
• The alternative segment is further sub-divided into black cohosh, vitamin E, herbal medicines, and others
• Based on distribution channel, the global menopausal hot flashes treatment market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies
• Each of the segments has been analyzed in detail for global menopausal hot flashes treatment market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights
• The global menopausal hot flashes report provides current and future revenues (US$ Mn) for each these segments for the period from 2017 to 2027, considering 2018 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2019 to 2027 along with menopausal hot flashes market size estimations.

Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2856

Regional Overview: Menopausal Hot Flashes Treatment Market

• In terms of region, the global menopausal hot flashes treatment market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further divided into major countries and sub-regions.
• The current and future market sizes for menopausal hot flashes treatment market in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report for the period from 2017 to 2027, with their CAGRs for the period from 2019 to 2027
• The study also offers a list of recommendations, highlights, and useful insights of the global menopausal hot flashes treatment market which will help new companies willing to enter the market and existing companies to increase market shares, and help in the decision-making process

Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=2856

Major Players

• The global menopausal hot flashes report concludes with the company profiles section that includes key information about the major players in the market
• Key players analyzed in this global menopausal hot flashes treatment market include -
• Pfizer Inc.
• Novartis AG
• Novo Nordisk A/S
• Allergan plc
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Hisamitsu Pharmaceutical Co., Inc.
• Merck & Co., Inc.
• GlaxoSmithKline plc
• TherapeuticsMD, Inc

Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=2856

• Each of these players has been profiled in the menopausal hot flashes treatment market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

More Trending Reports by Transparency Market Research:

Laboratory Gas Generators Market: https://www.transparencymarketresearch.com/laboratory-gas-generators-market.html

Critical Limb Ischemia Treatment Market - https://www.transparencymarketresearch.com/critical-limb-ischemia-treatment.html

Mice Model Technologies Market: https://www.transparencymarketresearch.com/mice-model-technologies-market.html

Motion Preservation Devices Market: https://www.transparencymarketresearch.com/motion-preservation-devices-market.html

Life Science Instrumentation Market: https://www.transparencymarketresearch.com/life-science-instrumentation-market.html

Benign Prostatic Hyperplasia Treatment Market: https://www.transparencymarketresearch.com/benign-prostatic-hyperplasia-treatment-market.html

Soft Tissue Allografts Market: https://www.transparencymarketresearch.com/soft-tissue-allografts-market.html

Non-invasive Ventilators Market: https://www.transparencymarketresearch.com/noninvasive-ventilators-market.html

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

Transcatheter Embolization and Occlusion Devices Market is projected to reach a value of US$ 5,799.8 Mn by the end of 2027

 

Transparency Market Research (TMR) has published a new report titled, ‘Transcatheter Embolization and Occlusion Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global transcatheter embolization and occlusion devices market was valued at US$ 2,957.4 Mn in 2018 and is projected to expand at a CAGR of 7.8% from 2019 to 2027. In terms of volume, the transcatheter embolization and occlusion devices were accounted at 72,93,954 units in 2018.

Request a Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2242

Overview

• Transcatheter embolization is a process of placing synthetic material or medication called embolic agent into blood vessels through a catheter to block blood flow toward a specific area of the body.
•  Embolization is a highly effective way to prevent abnormal bleeding and is minimally invasive as compared to open surgery. Additionally, the technology is proving its efficiency in treatment while performing complex surgeries.
• Surge in incidence of cardiovascular diseases, respiratory disorders, and cancer are anticipated to drive demand for transcatheter embolization and occlusion devices during the forecast period.
•  North America dominated the global transcatheter embolization and occlusion devices market in 2018 and the trend is anticipated to continue during the forecast period. Highly structured health care industry, increased adoption of minimally invasive surgeries, and introduction of the Affordable Care Act in the U.S. are expected to drive the market in North America.
• Asia Pacific is likely to be a highly lucrative market for transcatheter embolization and occlusion devices and it is expected to expand at a high CAGR during the forecast period

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=2242

High Prevalence of Obesity Drives Usage of Transcatheter Embolization and Occlusion Devices in Treatment of Peripheral Vascular Diseases

• Increase in obesity is leading to various disorders across the globe. According to the WHO, more than 1.9 billion adults were overweight in 2016. Of these over 650 million were obese. Most of the world's population lives in countries where overweight and obesity account more deaths than underweight.
• This is likely to increase the number of treatment procedures; consequently, propelling the global transcatheter embolization and occlusion devices market. The embolization coils segment is likely to account for major market share due to technologically advanced products adopted by health care providers.

Peripheral Vascular Disease Segment Accounted for Significant Market Share

• In terms of application, the global transcatheter embolization and occlusion devices market has been segmented into peripheral vascular disease, neurology, oncology, urology, and others. Peripheral vascular disease is projected to be a highly attractive segment during the forecast period.
• The segment is expected to continue to lead the market from 2019 to 2027 due to increase in geriatric population, changing lifestyles leading to a high prevalence of obesity, and rise in demand for minimally invasive procedures. However, the oncology segment is expected to expand at a high CAGR during the forecast period due to the rise in prevalence of cancer across the globe.

Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=2242

Diagnostic Centers to be Promising Segment

• In terms of end-user, the global transcatheter embolization and occlusion devices market has been classified into hospitals, ambulatory surgical centers, and clinics. The hospitals segment held major share of the global market in 2018.
• Growth of the hospitals segment can be attributed to the availability of multiple service options & devices and tie-ups with health care companies to enhance health care products and service offerings. Moreover, hospitals are the preferred choice due to availability of advanced technology and better health care services.
• The hospitals segment is expected to expand at a high CAGR, especially in developed countries, due to increase in geriatric population and rise in health care infrastructure and support. Additionally, surge in demand for transcatheter embolization and occlusion devices in ambulatory surgical centers during medical emergency is likely to drive the segment.

North America to Dominate Global Market

• In terms of region, the global transcatheter embolization and occlusion devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global transcatheter embolization and occlusion devices market in 2018, followed by Europe.
• The market in the North America is driven by highly developed health care sector, increase in awareness among health care providers about transcatheter embolization and occlusion devices, and continuous evolution of transcatheter embolization and occlusion devices.
• The Transcatheter Embolization and Occlusion Devices market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period due to increase in awareness about transcatheter embolization and occlusion devices for therapeutics. Moreover, expansion of the health care sector in countries such as China, Japan, and India offers immense potential in the region.
• Technological advancements and increase in rate of adoption of transcatheter embolization and occlusion devices products are expected to propel the market in the region during the forecast period.

Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=2242

Competitive Landscape

• The global transcatheter embolization and occlusion devices market is highly fragmented in terms of number of players providing different products. Key players in the global market include BTG plc, Boston Scientific Corporation, Medtronic plc, Penumbra, Inc., Cook Medical, Edwards Lifesciences Corporation, Merit Medical Systems, Johnson & Johnson Services, Inc., Pfizer, Inc., Stryker Corporation, Terumo Corporation, Sirtex Medical Limited, and Abbott Laboratories. Expansion of product portfolio through mergers and acquisitions is a key strategy followed by these players.

The global transcatheter embolization and occlusion devices market has been segmented as follows:

Global Transcatheter Embolization and Occlusion Devices Market, by Product

• Embolization Coils
• Coiling Assist Devices
• Embolization Particles
• Flow Diverter Devices
• Liquid Embolics
• Accessories

Global Transcatheter Embolization and Occlusion Devices Market, by Application

• Peripheral Vascular Disease
• Neurology
• Oncology
• Urology
• Others

Global Transcatheter Embolization and Occlusion Devices Market, by End-user

• Hospitals
• Ambulatory Surgical Centers
• Clinics

Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2242

Global Transcatheter Embolization and Occlusion Devices Market, by Region

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific          
• China
• India
• Japan
• Australia & New Zealand
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• GCC Countries
• South Africa
• Rest of Middle East & Africa

More Trending Reports by Transparency Market Research:

Motion Preservation Devices Market - https://www.transparencymarketresearch.com/motion-preservation-devices-market.html

Endoscope Washer Disinfector Market - https://www.transparencymarketresearch.com/endoscope-washerdisinfectors-market.html

Analytical Standards Market - https://www.transparencymarketresearch.com/analytical-standards-market.html

Biobanking Market - https://www.transparencymarketresearch.com/biobanking-market.html

Vitamin D Testing Market - https://www.transparencymarketresearch.com/vitamin-d-testing-market.html

Laboratory Gas Generators Market - https://www.transparencymarketresearch.com/laboratory-gas-generators-market.html

Critical Limb Ischemia Treatment Market - https://www.transparencymarketresearch.com/critical-limb-ischemia-treatment.html

Mice Model Technologies Market - https://www.transparencymarketresearch.com/mice-model-technologies-market.html

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

 

Pulmonary Drug Delivery Devices Market is likely to surpass US$ 49.5 Bn by 2031

Overview of Global Pulmonary Drug Delivery Devices Market

Pulmonary drug delivery systems refer to technologies that are used to treat diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis using pulmonary route of drug administration. These systems have been in medical use for more than six decades. However, recent technological advancements in pulmonary drug delivery systems have expanded their potential application in other diseases such as diabetes, lung cancer, and others.

The pulmonary drug delivery market deals with devices that help with the inhalation of drug formulation through mouth and further deposition of inhaled pharmacological agent in lower airways. The rise in prevalence of major respiratory problems such as COPD, asthma, and cystic fibrosis is a major factor driving the global pulmonary drug delivery devices market.

Request a Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=48993

The global pulmonary drug delivery devices market has been segmented on the basis of product type, application, and distribution channel. In terms of product type, the global pulmonary drug delivery devices market has been classified into dry powder inhalers, metered dose inhalers, and nebulizers. Based on application, the global pulmonary drug delivery devices market has been categorized into asthma, COPD, cystic fibrosis, and others.

In terms of distribution channel, the global pulmonary drug delivery devices market has been divided into retail pharmacies, hospital pharmacies, and e-commerce.

Increase in Prevalence and Incidence of Respiratory Diseases to Drive Global Market

The surge in trend of pulmonary drug delivery due to large absorptive area, thin absorptive mucosal membrane, and efficient blood supply is likely to propel the global pulmonary drug delivery devices market. The growing need of minimal invasive and effective treatment, and rise in the number of people with habit of smoking are projected to fuel the growth of the global pulmonary drug delivery devices market.

Moreover, increase in incidence of chronic respiratory diseases is projected to drive the demand for pulmonary drug delivery systems (PDDS) in the near future. According to data published by the Global Asthma Network (GAN) in “The Global Asthma Report 2014”, asthma affects around 334 million people globally. Rise in prevalence and incidence of respiratory diseases has led to an increase in the patient population, which in turn has fueled the demand for these systems. This consequent increase in demand is likely to propel the global market in the next few years.

Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=48993

Surge in Number of Initiatives Undertaken by Government and Non-Government Organizations

Rise in the number of initiatives undertaken by government and non-government organizations drives the global pulmonary drug delivery devices market, in terms of revenue. For instance, the CDC’s National Asthma Control Program (NACP) provides funds for educating asthma affected patients. Such initiatives are likely to increase awareness about asthma, which will drive the adoption of PDDS in the treatment of chronic obstructive pulmonary disease (COPD) and asthma.

High Adoption Rate of Metered Dose Inhalers for Effective Inhalation Therapy for Asthma

In terms of product type, the global pulmonary drug delivery devices market has been classified into dry powder inhalers, metered dose inhalers, and nebulizers. The metered dose inhalers (MDI) segment held key market share in 2020. Presence of major players involved in the development of novel MDIs and high acceptance rate of these devices in developing regions, such as Asia Pacific and Latin America, are the major factors propelling the segment.

Based on application, the global pulmonary drug delivery devices market has been categorized into asthma, COPD, cystic fibrosis, and others. The asthma segment held key share of the global market in 2020. An effective inhalation therapy that uses DPIs and MDIs is considered the basis of asthma management. The demand and usage of devices such as MDIs and DPIs for asthma management are increasing due to high number of people affected by asthma, which in turn fuels the growth of the asthma segment.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=48993

Rise in Hospitalizations to Fuel Growth of Global Pulmonary Drug Delivery Devices Market

Based on distribution channel, the global pulmonary drug delivery devices market has been categorized into retail pharmacies, hospital pharmacies, and e-commerce. The hospital pharmacies segment held notable share of the global pulmonary drug delivery devices market in 2021, and the trend is projected to continue in the near future. Hospitals offer extensive treatments, care, quick reimbursements, and insurance policies due to which patients prefer hospital pharmacies. Moreover, increase in the number of hospitalizations is anticipated to fuel the growth of the segment.

Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=48993

Regional Outlook of Global Pulmonary Drug Delivery Devices Market

In terms of region, the global pulmonary drug delivery devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global pulmonary drug delivery devices market in 2021, followed by Europe. This can be attributed to the increase in incidence of diseases such as COPD and asthma. Rise in the number of patients affected by these diseases increases the demand for diagnostic devices, including PDDS, thereby propelling the market in the region.

Analysis of Key Players in Global Pulmonary Drug Delivery Devices Market

This report by Transparency Market Research profiles key players in the global pulmonary drug delivery devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The global pulmonary drug delivery devices market is highly fragmented, with the presence of a number of international as well as regional players.

Leading players operating in the global pulmonary drug delivery devices market are Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Merck & Co., Inc., MannKind Corporation, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Mylan N.V., Omron Corporation, 3M Healthcare, Sunovion Pharmaceuticals, Inc., Koninklijke Philips N.V., Gerresheimer AG, Bespak, AptarGroup, Inc., SHL Group, Nypro Healthcare, Inc. (Jabil Circuit, Inc.), Hovione, and Chiesi Farmaceutici S.p.A., among others.

Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=48993

Key Developments in Global Pulmonary Drug Delivery Devices Market

The market is quite competitive, with key players engaged in mergers & acquisitions, new product development, collaborations & partnerships, and growth strategies to increase market penetration. Rise in the number of companies is expected to fuel competition in the near future. Hence, competitive rivalry in the respiratory market is expected to be high during the forecast period. Additionally, these players offer services that are aimed at enhancing the quality of drug delivery systems and better patient care. Moreover, the need of more efficient systems and competition among new entrants are anticipated to augment the global pulmonary drug delivery devices market in the next few years. Strategies adopted by players operating in the global pulmonary drug delivery devices market include:

• In May 2017, Koninklijke Philips N.V. entered into a definitive agreement to acquire Respiratory Technologies, Inc. (RespirTech) in order to expand its respiratory care product portfolio

More Trending Reports by Transparency Market Research:

Optical Lens Edger Market - https://www.transparencymarketresearch.com/optical-lens-edger-market.html

Bladder Scanners Market - https://www.transparencymarketresearch.com/bladder-scanner-market.html

Label-free Array Systems Market - https://www.transparencymarketresearch.com/label-free-array-systems-market.html

Diagnostic Imaging Services Market - https://www.transparencymarketresearch.com/diagnostic-imaging-services-market.html

Shoulder Replacement Market - https://www.transparencymarketresearch.com/shoulder-replacement-market.html

Canes and Crutches Market - https://www.transparencymarketresearch.com/canes-crutches-market.html

Motion Preservation Devices Market - https://www.transparencymarketresearch.com/motion-preservation-devices-market.html

Endoscope Washer Disinfector Market - https://www.transparencymarketresearch.com/endoscope-washerdisinfectors-market.html

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com